Maria-Rosa Bernal-Lopez
Overview
Explore the profile of Maria-Rosa Bernal-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Velasco M, Osuna-Sanchez J, Millan-Gomez M, Ricci M, Lopez-Sampalo A, Bernal-Lopez M, et al.
Med Clin (Barc)
. 2024 Dec;
PMID: 39665898
Introduction And Objectives: The role of in-hospital dipeptidyl peptidase-4 inhibitors in very old patients has not been widely described. This work analyzes the simplification of in-hospital antihyperglycemic management (less insulin...
2.
Saez Lancellotti T, Avena M, Funes A, Bernal-Lopez M, Gomez-Huelgas R, Fornes M
Nat Rev Urol
. 2024 Nov;
PMID: 39528754
The decline in male fertility correlates with the global rise in obesity and dyslipidaemia, representing significant public health challenges. High-fat diets induce metabolic alterations, including hypercholesterolaemia, hepatic steatosis and atherosclerosis,...
3.
Sanz-Canovas J, Ricci M, Cobos-Palacios L, Lopez-Sampalo A, Hernandez-Negrin H, Vazquez-Marquez M, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(2):36.
PMID: 39077405
The prevalence of type 2 diabetes mellitus (T2DM) is rising in the general population. This increase leads to higher cardiovascular risk, with cardiovascular diseases being the main cause of death...
4.
Gomez-Moyano E, Pavon-Moron J, Rodriguez-Capitan J, Bardan-Rebollar D, Ramos-Carrera T, Villalobos-Sanchez A, et al.
J Clin Med
. 2024 Apr;
13(8).
PMID: 38673677
The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients...
5.
Khoury N, Martinez M, Nishi S, Martinez-Gonzalez M, Corella D, Castaner O, et al.
Environ Int
. 2024 Apr;
186:108565.
PMID: 38574403
Background: Endocrine disruptors (EDs) have emerged as potential contributors to the development of type-2 diabetes. Perfluorooctane sulfonate (PFOS), is one of these EDs linked with chronic diseases and gathered attention...
6.
Khoury N, Martinez M, Paz-Graniel I, Martinez-Gonzalez M, Corella D, Castaner O, et al.
Environ Res
. 2023 Mar;
227:115697.
PMID: 36972775
Introduction: The principal source of exposure to Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo-p-furans (PCDD/Fs) in humans comes from food intake. PCDD/Fs, are a family of potential endocrine disruptors and have been...